![](https://investorshub.advfn.com/uicon/78991.png?cb=1630499252)
Friday, March 03, 2017 6:11:37 AM
Cellceutix has yet to file for Q2, but ended the first quarter with $5.15 million in cash, money that was drawn down from an original $10 million share purchase agreement from December 2012 and then upped to a new $20 million agreement in October 2013 that still had a balance of $18.4 million at the end of the first quarter.
http://seekingalpha.com/article/2422945-did-the-medicines-company-trump-cellceutix-and-others-in-a-1b-plus-skin-infection-market
And here we are in 2016, with a better profile and stronger pipeline. I just thought that was pretty interesting considering how well and how much has been accomplished on so little.
Really though, what my line of thinking this morning was how much Dr. Frei would have loved seeing Kevetrin advance to a trial in ovarian cancer. Dr. Frei was the president of the American Association for Cancer Research back in 1971. I wasn't aware of that. Here's the wiki link to the good Dr. https://en.wikipedia.org/wiki/Emil_Frei
For those that may not know some of the work Dr. Frei has put into Cellceutix just type in "Frei" on the company website or click here.
Kevetrin is making the stage again this time at the (AACR) Annual Meeting on April 4th http://www.abstractsonline.com/pp8/#!/4292/presentation/3876
We have a lot going on across the board with the pipeline. I just wanted to hit the pause button and reflect back a bit and remember what a vision not only Dr. Frei helped but also the hard work Dr. Menon and many others have done and are doing.
There is still great relevance to this article as well as some continuing discussion
Interview With New Cellceutix President Dr A Bertolino
http://seekingalpha.com/article/3988240-interview-new-cellceutix-president-dr-bertolino?v=1486123535&comments=show
"Perfection is not attainable, but if we chase perfection we can catch
excellence." Vince Lombardi
Do your research! Play the TA. All posts are my opinion.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM